Stock market week-in-review for 5 large GI companies — Nov. 27 to Dec. 1

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 27 to Dec. 1, 2017.

Note: This data was compiled using Yahoo Finance.

1. Allergan Pharmaceuticals

Opened: $173.59 on Nov. 27
Peaked: $179.85 on Nov. 29
Closed: $169.94 on Dec. 1
Percent change between Nov. 27 and Dec. 1: -2.10 percent

2. Exact Sciences Corp.

Opened: $59.49 on Nov. 27
Peaked: $59.97 on Nov. 30
Closed: $57.95 on Dec. 1
Percent change between Nov. 27 and Dec. 1: -2.58 percent

3. Johnson & Johnson

Opened: $137.51 on Nov. 27
Peaked: $140.53 on Nov. 28
Closed: $139.98 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 1.79 percent

4. Synergy Pharmaceuticals

Opened: $1.89 on Nov. 27
Peaked: $2.10 on Nov. 30
Closed: $2 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 5.82 percent

5. Valeant Pharmaceuticals

Opened: $16.55 on Nov. 27
Peaked: $17.62 on Dec. 1
Closed: $17.25 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 4.22 percent

More articles on gastroenterology: 
5 most read GI/endoscopy stories: Nov. 27-Dec. 1
GI leader to know: Dr. Edward Schirack of Clinical Gastroenterology
Grants increase CRC screening rates at federal health centers

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months